|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBSCO_ocm60193363 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
050504s2005 dcua ob 000 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCL
|d OCLCQ
|d YDXCP
|d OCLCQ
|d COF
|d OCLCQ
|d VRC
|d TUU
|d OCLCQ
|d ORU
|d CASUM
|d IDEBK
|d OCLCQ
|d ORU
|d OCLCO
|d OCLCQ
|d NLGGC
|d OCLCO
|d OCLCQ
|d EBLCP
|d OCLCQ
|d OCLCO
|d OCLCA
|d OCLCO
|d TOA
|d OCLCO
|d AGLDB
|d PIFBR
|d OCLCQ
|d ZCU
|d OCLCQ
|d MERUC
|d OCLCQ
|d SAV
|d OCLCQ
|d MERER
|d WY@
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d BUF
|d OCLCO
|d LUE
|d OCLCO
|d GILDS
|d OCLCO
|d OCLCF
|d VNS
|d OCLCO
|d VTS
|d ICG
|d OCLCO
|d INT
|d VT2
|d OCLCQ
|d WYU
|d OCLCO
|d OCLCA
|d S9I
|d STF
|d G3B
|d DKC
|d OCLCQ
|d OCLCO
|d UX1
|d OCLCQ
|d OCLCA
|d AJS
|d UKAHL
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|
016 |
7 |
|
|a 101254456
|2 DNLM
|
019 |
|
|
|a 642458791
|a 666928317
|a 923274427
|a 1055332040
|a 1064767737
|a 1081212734
|a 1152992446
|
020 |
|
|
|a 0309549256
|q (electronic bk.)
|
020 |
|
|
|a 9780309549257
|q (electronic bk.)
|
020 |
|
|
|a 9786612083327
|
020 |
|
|
|a 6612083328
|
020 |
|
|
|z 0309096081
|q (pbk.)
|
020 |
|
|
|z 9780309096089
|q (pbk.)
|
029 |
1 |
|
|a AU@
|b 000044591226
|
029 |
1 |
|
|a AU@
|b 000051501701
|
029 |
1 |
|
|a DEBBG
|b BV043160667
|
029 |
1 |
|
|a DEBBG
|b BV044108382
|
029 |
1 |
|
|a DEBSZ
|b 422323403
|
029 |
1 |
|
|a DKDLA
|b 820120-katalog:999943342405765
|
029 |
1 |
|
|a GBVCP
|b 801282713
|
035 |
|
|
|a (OCoLC)60193363
|z (OCoLC)642458791
|z (OCoLC)666928317
|z (OCoLC)923274427
|z (OCoLC)1055332040
|z (OCoLC)1064767737
|z (OCoLC)1081212734
|z (OCoLC)1152992446
|
043 |
|
|
|a n-us---
|
050 |
|
4 |
|a RA401.5
|b .N38 2005eb
|
060 |
|
4 |
|a 2005 J-394
|
060 |
|
4 |
|a QZ 275
|b M235 2005
|
072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
082 |
0 |
4 |
|a 615.19
|2 22
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Making better drugs for children with cancer /
|c Committee on Shortening the Time Line for New Cancer Treatments, National Cancer Policy Board ; Peter C. Adamson [and others], editors ; Institute of Medicine and National Research Council of the National Academies.
|
260 |
|
|
|a Washington, D.C. :
|b National Academies Press,
|c ©2005.
|
300 |
|
|
|a 1 online resource (xiv, 42 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a data file
|
504 |
|
|
|a Includes bibliographical references.
|
505 |
0 |
|
|a Childhood cancers: Background -- Agents in use and in testing for children with cancer -- The existing capacity for developing new agents specifically for childhood cancers -- Putting the pieces together -- Delays in testing approved agents in children -- The need to prioritize agents for testing in children with cancer -- Testing and labeling of drugs for pediatric use.
|
588 |
0 |
|
|a Print version record.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Drug approval
|z United States.
|
650 |
|
0 |
|a Cancer in children
|x Chemotherapy.
|
650 |
|
0 |
|a Children.
|
650 |
1 |
2 |
|a Neoplasms
|x drug therapy
|
650 |
2 |
2 |
|a Antineoplastic Agents
|
650 |
2 |
2 |
|a Child
|
650 |
2 |
2 |
|a Clinical Trials
|
650 |
2 |
2 |
|a Drug Approval
|
650 |
2 |
2 |
|a Neoplasms
|x epidemiology
|
651 |
|
2 |
|a United States
|
650 |
|
6 |
|a Médicaments
|x Autorisation de mise sur le marché
|z États-Unis.
|
650 |
|
6 |
|a Cancer chez l'enfant
|x Chimiothérapie.
|
650 |
|
6 |
|a Anticancéreux.
|
650 |
|
6 |
|a Enfants.
|
650 |
|
7 |
|a children (people by age group)
|2 aat
|
650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Children
|2 fast
|
650 |
|
7 |
|a Drug approval
|2 fast
|
651 |
|
7 |
|a United States
|2 fast
|
700 |
1 |
|
|a Adamson, Peter C.
|
710 |
2 |
|
|a National Cancer Policy Board (U.S.).
|b Committee on Shortening the Time Line for New Cancer Treatments.
|
776 |
0 |
8 |
|i Print version:
|t Making better drugs for children with cancer.
|d Washington, D.C. : National Academies Press, ©2005
|z 0309096081
|w (DLC) 2005282528
|w (OCoLC)60504477
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=131249
|z Texto completo
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH36616997
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL3377934
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 131249
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 208332
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 2293515
|
994 |
|
|
|a 92
|b IZTAP
|